{"id":905327,"date":"2025-11-04T15:32:59","date_gmt":"2025-11-04T20:32:59","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\/"},"modified":"2025-11-04T15:32:59","modified_gmt":"2025-11-04T20:32:59","slug":"broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\/","title":{"rendered":"Broadwood Partners Condemns Alcon\u2019s Fallacious Attacks on STAAR Surgical and Its Prospects"},"content":{"rendered":"

<\/p>\n

Broadwood Partners Condemns Alcon\u2019s Fallacious Attacks on STAAR Surgical and Its Prospects<\/b><\/p>\n

Reminds STAAR\u2019s Board That It Does Not Need Alcon\u2019s Permission to Remain Independent or Run a Proper Strategic Alternatives Process<\/i><\/b><\/p>\n

NEW YORK–(BUSINESS WIRE<\/a>)–
\nBroadwood Partners, L.P. and its affiliates (\u201cBroadwood\u201d or \u201cwe\u201d) today commented on the investor presentation issued by Alcon Inc. (\u201cAlcon\u201d) (NYSE: ALC) regarding its proposed acquisition of STAAR Surgical Company (\u201cSTAAR\u201d or the \u201cCompany\u201d) (NASDAQ: STAA). Broadwood, which owns 27.5% of STAAR\u2019s outstanding common stock, continues to urge its fellow shareholders to vote on its GREEN<\/span><\/b> Proxy Card \u201cAGAINST<\/span><\/b>\u201d the proposed transaction.\n<\/p>\n

\nNeal C. Bradsher, Broadwood Founder and President, said:\n<\/p>\n

\n\u201cToday\u2019s press release and presentation from Alcon, which required STAAR\u2019s approval, is disappointingly replete with fallacious arguments and baseless claims, all in service of preserving Alcon\u2019s privileged but misbegotten position as STAAR\u2019s chosen acquirer. We are dismayed that the STAAR Board, despite its fiduciary duty to STAAR shareholders, would sanction the publication of such misleading statements regarding STAAR\u2019s own business prospects and the integrity and results of two of its largest shareholders.\n<\/p>\n

\nGiven the overwhelmingly negative reaction of STAAR shareholders (and all three proxy advisors) to the timing, process and price of the proposed Alcon transaction, there is no reason for the Board of Directors to take direction from Alcon. There is no justification for prolonging this process, and the distraction and damage to STAAR\u2019s business it creates, for Alcon\u2019s benefit. Shareholders should be allowed to reject this transaction, as they were poised to do before the Board first adjourned, and then further postponed, the Special Meeting. After this deal is rightly rejected, the Board will have complete freedom to decide when and how, if at all, to conduct a sale process; the Board therefore does not need Alcon\u2019s permission to run a \u2018go-shop\u2019 and should not further delay the vote.\n<\/p>\n

\nLacking facts on their side and good arguments on the merits, Alcon and STAAR have taken instead to ad hominem<\/i> attacks. Needless to say, Alcon and STAAR have grossly misrepresented our track record in specific investments and overall, while ignoring our numerous successes: $1 million invested with Broadwood at the beginning of 2000 is now worth more than $47 million. If Alcon had generated annualized shareholder returns since its spinout in 2019 on par with our record, then Alcon\u2019s stock would be trading at more than $150 per share, instead of $75. Perhaps then Alcon would have the mandate from its own shareholders to pay a fair price for STAAR.\n<\/p>\n

\nWe continue to caution the STAAR Board against taking any substantive or procedural steps with respect to this transaction without the input and alignment of STAAR\u2019s shareholders.\u201d\n<\/p>\n

\nShareholders can learn more at www.LetSTAARShine.com<\/a>.\n<\/p>\n

About Broadwood<\/b><\/p>\n

\nBroadwood Partners, L.P. is managed by Broadwood Capital, Inc. Broadwood Capital is a private investment firm based in New York City. Neal C. Bradsher is the President of Broadwood Capital.\n<\/p>\n

Special Meeting of Shareholders Scheduled for October 23, 2025<\/span><\/p>\n

\nBroadwood Partners, L.P., Broadwood Capital, Inc., Neal C. Bradsher, Richard T. LeBuhn, Natalie R. Capasso, Raymond A. Myers and Jason J. Martin (collectively, the \u201cParticipants\u201d) are participants in the solicitation of proxies from the shareholders of STAAR in connection with the special meeting of shareholders scheduled for October 23, 2025 (including any adjournments, postponements, reschedulings or continuations thereof, the \u201cSpecial Meeting\u201d). The Participants have filed a definitive proxy statement on Schedule 14A (the \u201cDefinitive Proxy Statement\u201d) and accompanying GREEN<\/b> Proxy Card to be used in connection with any such solicitation of proxies from the Company\u2019s shareholders for the Special Meeting. SHAREHOLDERS OF STAAR ARE URGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT THE PARTICIPANTS HAVE FILED OR WILL FILE WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION (THE \u201cSEC\u201d) BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION, INCLUDING ABOUT THE MATTERS TO BE VOTED ON AT THE SPECIAL MEETING AND ADDITIONAL INFORMATION RELATING TO THE PARTICIPANTS AND THEIR DIRECT OR INDIRECT INTERESTS, BY SECURITY HOLDINGS OR OTHERWISE.<\/b> The Definitive Proxy Statement and accompanying GREEN<\/b> Proxy Card have been furnished to some or all of STAAR\u2019s shareholders and will be, along with other relevant documents, available at no charge on the SEC\u2019s website at https:\/\/www.sec.gov\/<\/a>.\n<\/p>\n

Special Meeting of Shareholders to Remove Members of the Board<\/span><\/p>\n

\nThe Participants also intend to file a definitive proxy statement and an accompanying GREEN<\/b> Proxy Card with the SEC to be used to solicit proxies with respect to removing members of the Board and any other proposals that may come before a future and yet to be called or otherwise scheduled special meeting of shareholders (including any adjournments, postponements, reschedulings or continuations thereof, the \u201cShareholder Meeting\u201d). The Shareholder Meeting will be separate, distinct and unrelated to the Special Meeting, and the Participants believe that the Shareholder Meeting will have no effect on the outcome of the Special Meeting. The Participants do not believe that there is any lawful reason that would prevent or prohibit the Participants from calling the Shareholder Meeting, regardless of the outcome of the shareholder vote at the Special Meeting, and do not make any representation related to whether the Company may contest, or otherwise challenge, the Participants\u2019 ability to call the Shareholder Meeting. SHAREHOLDERS OF THE COMPANY ARE URGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT THE PARTICIPANTS WILL FILE WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION, INCLUDING ABOUT THE MATTERS TO BE VOTED ON AT THE SHAREHOLDER MEETING AND ADDITIONAL INFORMATION RELATING TO THE PARTICIPANTS AND THEIR DIRECT OR INDIRECT INTERESTS, BY SECURITY HOLDINGS OR OTHERWISE<\/b>. The definitive proxy statement and an accompanying GREEN<\/b> Proxy Card will be furnished to some or all of the Company\u2019s shareholders and will be, along with other relevant documents, available at no charge on the SEC\u2019s website at https:\/\/www.sec.gov\/<\/a>.\n<\/p>\n

\nInformation about the Participants and a description of their direct or indirect interests, by security holdings or otherwise, is contained on an amendment to Schedule 13D filed by the Participants with the SEC on October 22, 2025 and is available here<\/a>.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20251104591082\/en\/<\/a><\/span><\/p>\n

Investor Contacts
\n<\/b>
John Ferguson \/ Joseph Mills
\n
Saratoga Proxy Consulting LLC
\n
jferguson@saratogaproxy.com
\n<\/a>
jmills@saratogaproxy.com
\n<\/a>
(212) 257-1311
\n
(888) 368-0379\n<\/p>\n

Media Contacts
\n<\/b>
Scott Deveau \/ Jeremy Jacobs
\n
August Strategic Communications
\n
Broadwood@AugustCo.com
\n<\/a>
(323) 892-5562\n<\/p>\n

KEYWORDS:<\/b> New York United States North America Canada<\/p>\n

INDUSTRY KEYWORDS:<\/b> Professional Services Health Medical Devices Surgery Finance Banking Optical<\/p>\n

MEDIA:<\/b><\/p>\n\n","protected":false},"excerpt":{"rendered":"

Broadwood Partners Condemns Alcon\u2019s Fallacious Attacks on STAAR Surgical and Its Prospects Reminds STAAR\u2019s Board That It Does Not Need Alcon\u2019s Permission to Remain Independent or Run a Proper Strategic Alternatives Process NEW YORK–(BUSINESS WIRE)– Broadwood Partners, L.P. and its affiliates (\u201cBroadwood\u201d or \u201cwe\u201d) today commented on the investor presentation issued by Alcon Inc. (\u201cAlcon\u201d) (NYSE: ALC) regarding its proposed acquisition of STAAR Surgical Company (\u201cSTAAR\u201d or the \u201cCompany\u201d) (NASDAQ: STAA). Broadwood, which owns 27.5% of STAAR\u2019s outstanding common stock, continues to urge its fellow shareholders to vote on its GREEN Proxy Card \u201cAGAINST\u201d the proposed transaction. Neal C. Bradsher, Broadwood Founder and President, said: \u201cToday\u2019s press release and presentation from Alcon, which required STAAR\u2019s approval, is disappointingly replete with … <\/p>\n

Continue reading “Broadwood Partners Condemns Alcon\u2019s Fallacious Attacks on STAAR Surgical and Its Prospects”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-905327","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBroadwood Partners Condemns Alcon\u2019s Fallacious Attacks on STAAR Surgical and Its Prospects - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Broadwood Partners Condemns Alcon\u2019s Fallacious Attacks on STAAR Surgical and Its Prospects - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Broadwood Partners Condemns Alcon\u2019s Fallacious Attacks on STAAR Surgical and Its Prospects Reminds STAAR\u2019s Board That It Does Not Need Alcon\u2019s Permission to Remain Independent or Run a Proper Strategic Alternatives Process NEW YORK–(BUSINESS WIRE)– Broadwood Partners, L.P. and its affiliates (\u201cBroadwood\u201d or \u201cwe\u201d) today commented on the investor presentation issued by Alcon Inc. (\u201cAlcon\u201d) (NYSE: ALC) regarding its proposed acquisition of STAAR Surgical Company (\u201cSTAAR\u201d or the \u201cCompany\u201d) (NASDAQ: STAA). Broadwood, which owns 27.5% of STAAR\u2019s outstanding common stock, continues to urge its fellow shareholders to vote on its GREEN Proxy Card \u201cAGAINST\u201d the proposed transaction. Neal C. Bradsher, Broadwood Founder and President, said: \u201cToday\u2019s press release and presentation from Alcon, which required STAAR\u2019s approval, is disappointingly replete with … Continue reading "Broadwood Partners Condemns Alcon\u2019s Fallacious Attacks on STAAR Surgical and Its Prospects"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-04T20:32:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251104591082r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Broadwood Partners Condemns Alcon\u2019s Fallacious Attacks on STAAR Surgical and Its Prospects\",\"datePublished\":\"2025-11-04T20:32:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\\\/\"},\"wordCount\":1115,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20251104591082r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\\\/\",\"name\":\"Broadwood Partners Condemns Alcon\u2019s Fallacious Attacks on STAAR Surgical and Its Prospects - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20251104591082r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2025-11-04T20:32:59+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20251104591082r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20251104591082r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Broadwood Partners Condemns Alcon\u2019s Fallacious Attacks on STAAR Surgical and Its Prospects\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Broadwood Partners Condemns Alcon\u2019s Fallacious Attacks on STAAR Surgical and Its Prospects - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\/","og_locale":"en_US","og_type":"article","og_title":"Broadwood Partners Condemns Alcon\u2019s Fallacious Attacks on STAAR Surgical and Its Prospects - Market Newsdesk","og_description":"Broadwood Partners Condemns Alcon\u2019s Fallacious Attacks on STAAR Surgical and Its Prospects Reminds STAAR\u2019s Board That It Does Not Need Alcon\u2019s Permission to Remain Independent or Run a Proper Strategic Alternatives Process NEW YORK–(BUSINESS WIRE)– Broadwood Partners, L.P. and its affiliates (\u201cBroadwood\u201d or \u201cwe\u201d) today commented on the investor presentation issued by Alcon Inc. (\u201cAlcon\u201d) (NYSE: ALC) regarding its proposed acquisition of STAAR Surgical Company (\u201cSTAAR\u201d or the \u201cCompany\u201d) (NASDAQ: STAA). Broadwood, which owns 27.5% of STAAR\u2019s outstanding common stock, continues to urge its fellow shareholders to vote on its GREEN Proxy Card \u201cAGAINST\u201d the proposed transaction. Neal C. Bradsher, Broadwood Founder and President, said: \u201cToday\u2019s press release and presentation from Alcon, which required STAAR\u2019s approval, is disappointingly replete with … Continue reading \"Broadwood Partners Condemns Alcon\u2019s Fallacious Attacks on STAAR Surgical and Its Prospects\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-04T20:32:59+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251104591082r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Broadwood Partners Condemns Alcon\u2019s Fallacious Attacks on STAAR Surgical and Its Prospects","datePublished":"2025-11-04T20:32:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\/"},"wordCount":1115,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251104591082r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\/","name":"Broadwood Partners Condemns Alcon\u2019s Fallacious Attacks on STAAR Surgical and Its Prospects - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251104591082r1&sid=flmnd&distro=nx&lang=en","datePublished":"2025-11-04T20:32:59+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251104591082r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251104591082r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/broadwood-partners-condemns-alcons-fallacious-attacks-on-staar-surgical-and-its-prospects\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Broadwood Partners Condemns Alcon\u2019s Fallacious Attacks on STAAR Surgical and Its Prospects"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/905327","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=905327"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/905327\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=905327"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=905327"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=905327"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}